What Causes Hs Triggers Genes And Risk Factors?

Hidradenitis suppurativa (HS) is a chronic skin condition that causes painful lumps, nodules, and abscesses under the skin, most often in areas where skin rubs together. The exact cause is not fully understood, but research shows it begins with blockage of hair follicles followed by inflammation. Genetics, immune system dysfunction, and environmental factors such as smoking and obesity all play significant roles in who develops HS and what triggers flare-ups.

What Is Hidradenitis Suppurativa Exactly?

HS is not acne, and it is not an infection you can catch. It is a chronic inflammatory disease of the hair follicles. The medical term for it is hidradenitis suppurativa, and it is sometimes called acne inversa, though that name is misleading.

The condition typically appears in the armpits, groin, buttocks, and under the breasts. These areas have many apocrine sweat glands and hair follicles. When the follicle becomes blocked, it can rupture beneath the skin. The body’s immune system responds with inflammation, which leads to the painful, recurring lumps and tunnels that define HS.

HS is more common than previously believed. Some estimates suggest it affects roughly 1 in 100 people, though many cases go undiagnosed for years. It is not contagious, and it is not caused by poor hygiene.

What Causes HS Triggers Genes And Risk Factors?

The development of HS involves three interacting factors: genetic predisposition, immune system dysregulation, and environmental triggers. No single cause explains every case.

Genetics clearly play a role. About 30 to 40 percent of people with HS have a family member with the condition. Researchers have identified mutations in genes involved in the gamma-secretase complex, which is important for cell signaling and follicle health. However, having these genetic variants does not guarantee you will develop HS. Many people with the mutations never show symptoms.

The immune system is the second piece. In HS, the immune response is overactive. Inflammation markers are elevated even in areas of skin that look normal. This suggests a systemic inflammatory state, not just a local skin problem.

Environmental factors are the third piece. Smoking and obesity are the two strongest modifiable risk factors. Smoking is associated with more severe disease. Obesity increases mechanical friction and skin-to-skin contact, which may trigger follicle blockage. Hormonal factors may also influence HS, as symptoms often change with the menstrual cycle in women.

How Do Genes Influence HS Development?

Genetic studies have identified several pathways that contribute to HS. The most well-studied are mutations in the NCSTN, PSENEN, and PSEN1 genes. These genes encode components of the gamma-secretase complex, an enzyme that processes proteins involved in cell signaling.

When gamma-secretase function is impaired, hair follicle cells do not develop normally. The follicle can become blocked more easily, and the surrounding skin may respond to injury with excessive inflammation. This helps explain why HS tends to start in areas with high friction and many hair follicles.

Not everyone with HS has these mutations. Many cases are sporadic, meaning they occur without a family history. This suggests that multiple genes contribute, and environmental factors can trigger disease in people who are genetically susceptible.

Some research also points to alterations in the Notch signaling pathway, which regulates cell growth and differentiation. Disruption of this pathway is linked to the abnormal follicle behavior seen in HS.

What Role Does the Immune System Play?

HS is now understood as an autoinflammatory condition, not an autoimmune disease. The distinction matters. In autoimmune diseases, the immune system attacks specific body tissues. In autoinflammatory conditions, the immune system is activated without a clear target, producing inflammation in response to triggers that would normally be harmless.

In HS, immune cells called macrophages and T cells accumulate around blocked follicles. They release inflammatory cytokines, particularly tumor necrosis factor-alpha (TNF-alpha) and interleukins 17 and 1-beta. These molecules drive the pain, swelling, and tissue damage seen in HS.

This understanding has led to targeted treatments. Biologic drugs that block TNF-alpha, such as adalimumab, are approved for HS. Other biologics that target interleukins are being studied and used off-label. The fact that these drugs help confirms that immune dysregulation is central to the disease process.

It is important to note that HS is not caused by a single infection. While bacteria can colonize the lesions, they are secondary. Treating with antibiotics alone does not cure HS, though they can help manage flares in some people.

Which Lifestyle Factors Trigger Flare-Ups?

Several lifestyle factors are associated with more frequent or more severe HS flares. Smoking is the most consistent trigger identified in research. People who smoke tend to have earlier onset of disease and more extensive involvement. Quitting smoking may improve outcomes, though it does not cure HS.

Obesity is another major factor. Excess weight increases friction in skin folds and may promote follicle blockage. Weight loss, even modest, has been shown to reduce disease severity in some studies. Maintaining a healthy weight is one of the most practical steps people can take to manage HS.

Other potential triggers include:

• Skin friction from tight clothing or athletic gear
• Heat and sweating
• Hormonal changes, particularly around menstruation
• Stress, which can worsen inflammation
• Mechanical trauma such as shaving or skin picking

Diet is a topic of active research. Some people report that dairy or high-glycemic foods worsen their symptoms. The evidence is limited, and no specific diet is proven to treat HS. However, reducing dairy intake is a reasonable trial for some patients, given the absence of strong evidence either way.

Are There Other Health Conditions Linked to HS?

HS is associated with several other conditions, likely due to shared inflammatory pathways. Metabolic syndrome, which includes obesity, high blood pressure, high blood sugar, and abnormal cholesterol, is more common in people with HS.

Inflammatory bowel disease, particularly Crohn’s disease, is also linked to HS. Both conditions involve dysregulated immune responses and may respond to similar biologic treatments.

Polycystic ovary syndrome (PCOS) appears more frequently in women with HS. This may reflect hormonal influences on the disease. Depression and anxiety are also more common in people with HS, which is not surprising given the chronic pain and visible skin changes.

These associations do not mean HS causes these conditions. Rather, they suggest shared underlying mechanisms. If you have HS, your doctor may screen for these related conditions, especially if you have other symptoms.

Can HS Be Prevented?

There is no guaranteed way to prevent HS, especially if you have a strong genetic predisposition. However, addressing modifiable risk factors can reduce the likelihood of developing the condition or lower its severity.

Not smoking is the single most important preventive step. Avoiding weight gain and maintaining a healthy body weight also reduces risk. For people who already have HS, these same measures can help reduce flare frequency.

Early diagnosis and treatment may prevent progression. HS can worsen over time if untreated, with tunnels and scarring forming under the skin. Seeing a dermatologist early, ideally within the first year of symptoms, is associated with better outcomes.

No screening test exists for HS. If you have a family history and notice recurrent painful lumps in skin folds, seek medical evaluation rather than waiting. A dermatologist can diagnose HS based on clinical examination and medical history.

What Are the Treatment Options?

Treatment for HS depends on severity. Mild cases may respond to topical antibiotics, such as clindamycin. These reduce bacterial load and inflammation on the skin surface.

Moderate cases often require oral antibiotics, particularly tetracyclines or combination therapy. These are used for their anti-inflammatory effects, not just their antibacterial properties. Some clinicians recommend oral retinoids, though evidence for their effectiveness in HS is mixed.

Severe or refractory HS may require biologic therapy. Adalimumab is FDA-approved for HS. Other biologics, including secukinumab and infliximab, are used based on clinical evidence, though not all are formally approved for this indication.

Surgical options exist for chronic tunnels and scarring. Procedures range from drainage of acute abscesses to wide excision of affected skin areas. Surgery can provide significant relief, but recurrence is possible if the underlying inflammatory process is not controlled.

Pain management is an important but often overlooked component of HS care. Over-the-counter pain relievers may help for mild flares. For chronic pain, a pain specialist may be needed. Do not ignore pain as just part of the condition — it deserves proper attention.

When Should You See a Doctor?

See a doctor if you have recurrent painful lumps in your armpits, groin, or under your breasts that do not heal quickly. Early diagnosis matters. HS that is treated early is easier to manage and less likely to cause permanent scarring.

Seek urgent care if you develop signs of a serious infection, such as spreading redness, fever, or severe pain. While HS itself is not an infection, the lesions can become secondarily infected. This is a medical emergency that requires prompt treatment.

Do not attempt to pop or drain HS lesions yourself. This can worsen inflammation and increase the risk of infection and scarring. A dermatologist can perform drainage safely when needed.